A detailed history of Baader Bank Aktiengesellschaft transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Baader Bank Aktiengesellschaft holds 53,000 shares of ADMA stock, worth $1.07 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
53,000
Previous 46,000 15.22%
Holding current value
$1.07 Million
Previous $514,000 106.03%
% of portfolio
0.06%
Previous 0.03%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

BUY
$11.21 - $20.03 $78,470 - $140,210
7,000 Added 15.22%
53,000 $1.06 Million
Q2 2024

Jul 17, 2024

BUY
$5.98 - $11.18 $275,080 - $514,280
46,000 New
46,000 $514,000

Others Institutions Holding ADMA

About ADMA BIOLOGICS, INC.


  • Ticker ADMA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 196,356,992
  • Market Cap $3.97B
  • Description
  • ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...
More about ADMA
Track This Portfolio

Track Baader Bank Aktiengesellschaft Portfolio

Follow Baader Bank Aktiengesellschaft and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baader Bank Aktiengesellschaft, based on Form 13F filings with the SEC.

News

Stay updated on Baader Bank Aktiengesellschaft with notifications on news.